[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100159358":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":79,"locations":89,"responsibleParty":100,"collaborators":103,"id":127,"slug":128,"hasResults":129,"nctId":130,"briefTitle":131,"officialTitle":132,"acronym":133,"eligibilityCriteria":134,"healthyVolunteers":129,"sex":135,"minAge":136,"maxAge":7,"enrollmentInfo":137,"targetDuration":7,"studyType":140,"phases":7,"briefSummary":141,"conditions":142,"keywords":144,"overallStatus":91,"whyStopped":7,"lastUpdateSubmitDate":147,"lastUpdatePostDateStruct":148,"startDateStruct":151,"completionDateStruct":153,"leadSponsor":155,"locationsCount":156},{"fullName":5,"class":6},"Hospital Italiano de Buenos Aires","OTHER",null,[9,13,16,18,20,22,24,26,28,30,32,34,36,38,41,44,47,49,52,55,58,61,64,66,69,73,76],{"name":10,"affiliation":11,"role":12},"María Lourdes Posadas-Martínez, MD","Hospital Italiano de Buenos Aires, Argentina","PRINCIPAL_INVESTIGATOR",{"name":14,"affiliation":11,"role":15},"Elsa Nucifora, MD","STUDY_CHAIR",{"name":17,"affiliation":11,"role":15},"Diego Hernan Giunta, MD",{"name":19,"affiliation":11,"role":15},"Dorotea Fantl, MD",{"name":21,"affiliation":11,"role":15},"Gustavo Greloni, MD",{"name":23,"affiliation":11,"role":15},"Maria Adela Aguirre, MD",{"name":25,"affiliation":11,"role":15},"Cesar Antonio Belziti, MD",{"name":27,"affiliation":11,"role":15},"Patricia Sorroche",{"name":29,"affiliation":11,"role":15},"Soledad Saez",{"name":31,"affiliation":11,"role":15},"Erika Brulc, MD",{"name":33,"affiliation":11,"role":15},"Diego Perez de Arenaza, MD",{"name":35,"affiliation":11,"role":15},"Eugenia Villanueva, MD",{"name":37,"affiliation":11,"role":15},"Marcelina Carretero, MD",{"name":39,"affiliation":40,"role":12},"Carolina María Petit Cwirko, MD","Clinica Foianini, Santa Cruz, Bolivia",{"name":42,"affiliation":43,"role":12},"Pablo Young, MD","Hospital Británico, Buenos Aires, Argentina",{"name":45,"affiliation":46,"role":12},"Gisela Streitenberger, MD","Hospital de Alta Complejidad El Cruce Nestor Kirchner, Buenos Aires, Argentina",{"name":48,"affiliation":43,"role":15},"Luciana Leon Cejas, MD",{"name":50,"affiliation":51,"role":12},"Veronica Volberg, MD","Hospital de Clínicas José de San Martin, Buenos Aires, Argentina",{"name":53,"affiliation":54,"role":12},"Sergio Juan Baratta, MD","Hospital Austral, Buenos Aires, Argentina",{"name":56,"affiliation":57,"role":12},"Juan Pablo Costabel, MD","Instituto cardiovascular Buenos Aires, Argentina",{"name":59,"affiliation":60,"role":12},"Carlos Dumont Dunayevich, MD","Hospital Privado de Rosario, Santa Fe, Argentina",{"name":62,"affiliation":63,"role":12},"Alejandro Quiroga, MD","Fundación Favaloro, Buenos Aires, Argentina",{"name":65,"affiliation":63,"role":15},"Adrian Fernandez, MD",{"name":67,"affiliation":68,"role":12},"Josefina Parodi, MD","Anchorena, Buenos Aires, Argentina",{"name":70,"affiliation":71,"role":72},"Franco Leoni, MD","Médica Uruguaya, Uruguay","STUDY_DIRECTOR",{"name":74,"affiliation":75,"role":72},"Eduardo Ortuño Campos, MD","Hospital Universitarios Austral, Buenos Aires, Argentina",{"name":77,"affiliation":78,"role":12},"Jorge Thierer, MD","CEMIC, , Buenos Aires, Argentina",[80,86],{"name":81,"role":82,"phone":83,"phoneExt":84,"email":85},"María L Posadas-Martínez, MD, PhD","CONTACT","+54 11 4959 0200","9353","maria.posadas@hospitalitaliano.org.ar",{"name":87,"role":82,"phone":83,"phoneExt":84,"email":88},"Adela Aguirre, MD, PhD","adela.aguirre@hospitalitaliano.org.ar",[90],{"facility":5,"status":91,"city":92,"state":92,"zip":93,"country":94,"countryCode":95,"cosmosGeoPoint":7,"geoPoint":7,"contacts":96},"RECRUITING","Buenos Aires","C1199","Argentina","AR",[97],{"name":98,"role":82,"phone":99,"phoneExt":84,"email":85},"Maria L Posadas-Martinez, MD","54 11 4959 0200",{"type":12,"investigatorFullName":101,"investigatorTitle":102,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"MARIA LOURDES POSADAS MARTINEZ","MD, PHD",[104,106,108,110,112,114,117,119,121,123,125],{"name":105,"class":6},"Instituto Cardiovascular de Buenos Aires",{"name":107,"class":6},"Austral University, Argentina",{"name":109,"class":6},"Hospital de Alta Complejidad en Red",{"name":111,"class":6},"Hospital de Clinicas José de San Martín",{"name":113,"class":6},"HOSPITAL BRITANICO DE BUENOS AIRES",{"name":115,"class":116},"Hospital Privado de Rosario","UNKNOWN",{"name":118,"class":6},"Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno",{"name":120,"class":6},"La Fundacion Favaloro para la Investigacion y la Docencia Medica",{"name":122,"class":116},"Sanatorio Anchorena",{"name":124,"class":116},"Centro Médico Uruguayo, Uruguay",{"name":126,"class":116},"Clínica Foianini, Bolivia","100159358","hiba-institutional-registry-of-amyloidosis-100159358",false,"NCT01347047","HIBA-Institutional Registry of Amyloidosis","Institutional Registry of Amyloidosis (Hospital Italiano de Buenos Aires)","RIA-HIBA","Cases of amyloidosis are captured by electronic medical records whenever the physician register amyloidosis as a patient diagnosis, and\u002For there is amyloidosis in a biopsy specimen and\u002For requests for the following studies of an adult patient: plasma kappa and lambda light-chain concentrations, the kappa: lambda ratio, transthoracic Doppler echocardiography, or cardiovascular magnetic resonance examination or pyrophosphate scintigraphy From the possible cases included in the IRA, a prospective review of the electronics health records was performed to confirm the presence of amyloidosis\n\n\\*\\*Inclusion Criteria: 1 AND (2 or 3)\n\n1. Patients over 18 years:\n2. Confirmed amyloidosis: Proof of deposit of amyloid pathology by tissue biopsy in abdominal fat, bone marrow, rectum or organ involved (eg, kidney, liver, sural nerve)\n3. Clinically compatible case of Amyloidosis :\n\n   * Exclusion Criteria:\n\nRefusal to participate in the study or the informed consent process by the patient or legal representative or refusal to consent to participate in the study in the case of minors.","ALL","18 Years",{"count":138,"type":139},500,"ESTIMATED","OBSERVATIONAL","1. Creating a population-based registry system Amyloidosis prospective epidemiological survey\n\n   * risk factors\n   * diagnosis\n   * prognosis\n   * treatment\n   * monitoring\n   * survival\n2. Describe the occurrence of amyloidosis in the population of HIBA, Hospital Italiano de Buenos Aires.\n3. Describe the characteristics of clinical presentation, evolution and predisposing factors of amyloidosis.",[143],"Amyloidosis",[143,145,146],"Known or Suspected","rare diseases","2026-01-20",{"date":149,"type":150},"2026-01-22","ACTUAL",{"date":152,"type":150},"2011-04",{"date":154,"type":139},"2030-01",{"name":5,"class":6},1]